StockNews.com assumed coverage on shares of Edap Tms (NASDAQ:EDAP - Free Report) in a report published on Saturday. The firm issued a hold rating on the medical equipment provider's stock.
Edap Tms Price Performance
NASDAQ EDAP remained flat at $2.50 during trading hours on Friday. 38,548 shares of the company were exchanged, compared to its average volume of 42,794. The company has a market cap of $92.75 million, a price-to-earnings ratio of -3.85 and a beta of 0.36. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. Edap Tms has a one year low of $2.00 and a one year high of $8.50. The business's 50-day simple moving average is $2.28 and its 200-day simple moving average is $2.88.
Edap Tms (NASDAQ:EDAP - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The medical equipment provider reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of ($0.16) by ($0.03). Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The company had revenue of $14.42 million during the quarter, compared to the consensus estimate of $17.00 million. During the same period in the prior year, the firm earned ($0.12) earnings per share. Sell-side analysts forecast that Edap Tms will post -0.6 EPS for the current fiscal year.
Hedge Funds Weigh In On Edap Tms
A number of hedge funds have recently added to or reduced their stakes in the company. Redhawk Wealth Advisors Inc. purchased a new position in shares of Edap Tms during the third quarter valued at approximately $36,000. Illumine Investment Management LLC purchased a new stake in Edap Tms during the 4th quarter valued at $50,000. BNP Paribas Financial Markets raised its stake in Edap Tms by 23.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider's stock valued at $59,000 after buying an additional 4,400 shares during the last quarter. Orion Capital Management LLC lifted its holdings in shares of Edap Tms by 10.4% during the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider's stock valued at $178,000 after buying an additional 6,600 shares during the period. Finally, Parkman Healthcare Partners LLC purchased a new position in shares of Edap Tms in the 3rd quarter worth $395,000. 62.74% of the stock is currently owned by hedge funds and other institutional investors.
About Edap Tms
(
Get Free Report)
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.
Further Reading
Before you consider Edap Tms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Edap Tms wasn't on the list.
While Edap Tms currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
